Systematic review explores cannabinoids in treating dystonia in children, indicating their potential benefits.
Background/Purpose: Dystonia is a movement disorder characterized by sustained or intermittent involuntary muscle contractions, causing contorted movements or abnormal posturing. Symptoms often significantly impair quality of life, yet current pharmacological treatments are limited and frequently insufficient. Interestingly, cannabinoids have emerged as promising therapeutics; however, clinical evidence supporting their use, particularly in pediatric populations, remains sparse. This study presents a comprehensive systematic review of existing literature, complemented by an analysis of the largest cohort of pediatric patients treated with cannabinoids for dystonia.
No takes yet. Share an insight, caveat, or question.
Schipper et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: